Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
258 studies found for:    nichd AIDS/HIV
Show Display Options
RSS Create an RSS feed from your search for:
nichd AIDS/HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
2 Completed
Has Results
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
Conditions: Disease Transmission, Vertical;   Vertical Human Immunodeficiency Virus Transmission;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Nevirapine (NVP);   Drug: Epivir (3TC);   Drug: Nelfinavir (NFV)
3 Completed
Has Results
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: ATV;   Drug: Ritonavir
4 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
5 Completed
Has Results
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
Condition: HIV Infections
Interventions: Drug: NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT);   Drug: NNRTIs (EFV, NVP);   Drug: PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)
6 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
7 Completed Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
Condition: HIV Infections
Interventions: Biological: rMVA-HIV (env/gag [TBC-M358] + tat/rev/nef-RT [TBC-M335)]);   Biological: rFPV-HIV (env/gag [TBC-F357] + tat/rev/nef-RT [TBC-F349])
8 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
9 Completed Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Didanosine;   Drug: Efavirenz;   Drug: Emtricitabine
10 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
11 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
12 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
13 Completed Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
Condition: HIV Infections
Intervention: Drug: Lopinavir/Ritonavir
14 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
15 Completed Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Condition: HIV Infections
Interventions: Biological: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed;   Biological: Diphtheria and Tetanus Toxoids Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed;   Drug: Bacteriophage phi X 174;   Drug: Aldesleukin
16 Completed
Has Results
Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
17 Completed
Has Results
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Biological: Quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle (VLP) or Quadrivalent human papillomavirus vaccine (QHPV);   Other: Placebo/QHPV
18 Completed A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine
19 Completed A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
Condition: HIV
20 Completed A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Lamivudine;   Drug: Zidovudine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years